Study Stopped
Unable to reach the required sample size
Study of Treatment of Lisfranc Injuries
A Multi-center, Prospective, Randomised Study of Treatment of Lisfranc Injuries
1 other identifier
interventional
69
1 country
1
Brief Summary
This trial is designed to compare different treatments on Lisfranc fractures. The trial consist of 2 different strata. Stratum 1: In mild injuries the comparison is between conservative treatment and operative treatment with open reduction and internal fixation (ORIF). Stratum 2: In severe injuries the comparison is between operative treatment with open reduction and internal fixation (ORIF) and primary arthrodesis. The primary outcome measure will be AOFAS Midfoot Score, and secondary outcome measure will be VAS Foot and Ankle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 24, 2016
CompletedFirst Posted
Study publicly available on registry
November 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedNovember 13, 2023
November 1, 2023
11.4 years
October 24, 2016
November 9, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
AOFAS Midfoot Scale
Between group difference in the functional outcome of the foot measured with AOFAS Midfoot Scale which is a subjective and objective evaluation of the midfoot based on questions in function (45 points), pain (40 points), and alignment (15 points) with a total score between 0 (worst score) and 100 (perfect score).
12 months
AOFAS Midfoot Scale
Between group difference in the functional outcome of the foot measured with AOFAS Midfoot Scale which is a subjective and objective evaluation of the midfoot based on questions in function (45 points), pain (40 points), and alignment (15 points) with a total score between 0 (worst score) and 100 (perfect score).
24 months
Secondary Outcomes (8)
VAS Foot and Ankle
12 months
VAS Foot and Ankle
24 months
VAS Pain
6 weeks
VAS Pain
10 weeks
VAS Pain
4 months
- +3 more secondary outcomes
Other Outcomes (1)
Additional procedures or complications
up to 24months
Study Arms (3)
Open reduction and internal fixation
ACTIVE COMPARATORAfter operative treatment non-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.
Primary Arthrodesis
ACTIVE COMPARATORAfter operative treatment non-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.
Conservative treatment
ACTIVE COMPARATORNon-weightbearing cast immobilisation for 6 weeks. Cast will be changed after 2 weeks. After the 6 weeks cast will be replaced with orthotics. Orthotics will remain for 4 weeks.
Interventions
Stratum 1: Conservative treatment versus open reduction and internal fixation Stratum 2: Open reduction and internal fixation versus arthrodesis
Conservative treatment versus open reduction and internal fixation
Eligibility Criteria
You may qualify if:
- Stratum 1:
- Nondislocated fractures affecting tarsometatarsal (TMT) joints II and III
- Dislocation \<5mm between medial cuneiforme and base of II metatarsal (MT)
- No fractures affecting TMT joints IV and V
- Stratum 2:
- Affected joints TMT II- III + any other TMT
- Any dislocation \>2mm (fracture or TMT joint)
- Dislocation \>5mm between medial cuneiforme and base of II MT
You may not qualify if:
- Open fractures
- Extra-articular metatarsal (MT) fractures
- Extremely comminuted fractures with bone loss, and slight chance of gaining proper reduction with screws
- Patients with multiple fractures
- Patients with weak co-operation (dementia, alcohol use, etc.)
- Patients with significant neuropathy or some other neurological condition, diabetes and rheumatoid arthritis
- Patients with severe circulatory disorder of the lower limb
- Injuries over 14 days
- Patients with previous foot injury or surgery
- Pregnancy
- Patients who refuse to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tampere University Hospitallead
- Seinajoki Central Hospitalcollaborator
Study Sites (1)
Tampere University Hospital
Tampere, 33521, Finland
Related Publications (2)
Ponkilainen V, Maenpaa H, Laine HJ, Partio N, Vaisto O, Jousmaki J, Mattila VM, Haapasalo H. Open Reduction Internal Fixation vs Primary Arthrodesis for Displaced Lisfranc Injuries: A Multicenter Randomized Controlled Trial. Foot Ankle Int. 2024 Jun;45(6):612-620. doi: 10.1177/10711007241232667. Epub 2024 Mar 14.
PMID: 38482816DERIVEDPonkilainen VT, Mattila VM, Laine HJ, Paakkala A, Maenpaa HM, Haapasalo HH. Nonoperative, open reduction and internal fixation or primary arthrodesis in the treatment of Lisfranc injuries: a prospective, randomized, multicenter trial - study protocol. BMC Musculoskelet Disord. 2018 Aug 21;19(1):301. doi: 10.1186/s12891-018-2222-4.
PMID: 30126393DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Heikki-Jussi Laine, MD; PhD
Tampere University
- STUDY CHAIR
Tiina Kaistila, MS
Tampere University
- STUDY CHAIR
Ville Mattila, Professor
Tampere University
- STUDY CHAIR
Antti Paakkala, MD;PhD
Tampere University
- STUDY CHAIR
Heikki Mäenpää, Docent
Tampere University
- STUDY CHAIR
Mikko Kirjavainen, MD; PhD
Dextra Fertility Clinic
- STUDY CHAIR
Janne Jousmäki, MD
Seinajoki Central Hospital
- STUDY CHAIR
Olli Väistö, MD; PhD
Seinajoki Central Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
October 24, 2016
First Posted
November 2, 2016
Study Start
March 1, 2012
Primary Completion
August 1, 2023
Study Completion
August 1, 2023
Last Updated
November 13, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share